Patient engagement in healthcare: a preliminary set of measures to evaluate patient engagement in the European Reference Networks.

D. Marinello, I. Galetti, D. Dan, Ammi Sundqvist Andersson, Silvia Aguilera, S. Louisse, L. Wiehe, Anne-Laure Aslanian, Ines Hernando Martin
{"title":"Patient engagement in healthcare: a preliminary set of measures to evaluate patient engagement in the European Reference Networks.","authors":"D. Marinello, I. Galetti, D. Dan, Ammi Sundqvist Andersson, Silvia Aguilera, S. Louisse, L. Wiehe, Anne-Laure Aslanian, Ines Hernando Martin","doi":"10.20517/RDODJ.2021.001","DOIUrl":null,"url":null,"abstract":"Aim: The European Reference Networks (ERNs) provide clinicians and patients the opportunity to collaborate at EU level to improve diagnosis, care and treatment for people living with rare and complex conditions. However, building a partnership culture to systematically involve patients in ERN activities and decision-making structures is challenging, partly because the role of patient representatives and the value of this collaboration are not always understood. The objective of this project was to develop an evaluation framework to assess the impact of patient engagement in the ERNs and to provide evidence on the value of patient-clinician partnership. Methods: The evaluation was developed by EURORDIS and patient representatives involved in the ERNs (ePAG advocates) through a participatory and iterative process. The work was organised in three different phases: (1) clarify roles and identify common goals for ePAG advocates’ engagement in the ERNs; (2) define a set of measures; and (3) test the measures in three different ePAGs (European Patient Advocacy Groups). Results: The project allowed developing a common understanding among ePAG advocates of their role and goals in the ERNs and defining a patient-driven evaluation framework to assess their level of engagement in the ERNs’ activities and how effectively they were working to fulfil their role. Conclusion: Engaging with ERN clinicians to refine the framework would probably render it more relevant to the reality and priorities of the specific ERNs and more valuable as a tool to build a strong partnership culture. Such an evaluation framework could be integrated into the ERNs’ quality improvement system to ensure that the networks’ activities are driven by and remain responsive to patients’ needs.","PeriodicalId":74638,"journal":{"name":"Rare disease and orphan drugs journal","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rare disease and orphan drugs journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20517/RDODJ.2021.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Aim: The European Reference Networks (ERNs) provide clinicians and patients the opportunity to collaborate at EU level to improve diagnosis, care and treatment for people living with rare and complex conditions. However, building a partnership culture to systematically involve patients in ERN activities and decision-making structures is challenging, partly because the role of patient representatives and the value of this collaboration are not always understood. The objective of this project was to develop an evaluation framework to assess the impact of patient engagement in the ERNs and to provide evidence on the value of patient-clinician partnership. Methods: The evaluation was developed by EURORDIS and patient representatives involved in the ERNs (ePAG advocates) through a participatory and iterative process. The work was organised in three different phases: (1) clarify roles and identify common goals for ePAG advocates’ engagement in the ERNs; (2) define a set of measures; and (3) test the measures in three different ePAGs (European Patient Advocacy Groups). Results: The project allowed developing a common understanding among ePAG advocates of their role and goals in the ERNs and defining a patient-driven evaluation framework to assess their level of engagement in the ERNs’ activities and how effectively they were working to fulfil their role. Conclusion: Engaging with ERN clinicians to refine the framework would probably render it more relevant to the reality and priorities of the specific ERNs and more valuable as a tool to build a strong partnership culture. Such an evaluation framework could be integrated into the ERNs’ quality improvement system to ensure that the networks’ activities are driven by and remain responsive to patients’ needs.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
患者参与医疗保健:一套初步措施,以评估患者参与欧洲参考网络。
目的:欧洲参考网络(ern)为临床医生和患者提供了在欧盟层面合作的机会,以改善对罕见和复杂疾病患者的诊断、护理和治疗。然而,建立一种伙伴关系文化,使患者系统地参与ERN活动和决策结构是具有挑战性的,部分原因是患者代表的作用和这种合作的价值并不总是被理解。该项目的目的是建立一个评估框架,以评估患者参与急诊室的影响,并为患者-临床伙伴关系的价值提供证据。方法:评估由EURORDIS和参与ern的患者代表(ePAG倡导者)通过参与式和迭代过程制定。这项工作分三个阶段进行:(1)厘清环境工作计划倡议者参与环境工作计划的角色和共同目标;(二)确定一套措施;(3)在三个不同的ePAGs (European Patient Advocacy Groups)中测试这些措施。结果:该项目使ePAG的倡导者对他们在护士网络中的作用和目标达成了共识,并定义了一个以患者为导向的评估框架,以评估他们参与护士网络活动的程度,以及他们如何有效地履行自己的职责。结论:与ERN临床医生合作完善框架可能会使其更符合具体ERN的现实和优先事项,并且作为建立强大伙伴关系文化的工具更有价值。这样的评估框架可以整合到急诊室的质量改进系统中,以确保网络的活动是由患者的需求驱动的,并始终对患者的需求作出反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Fabry nephropathy: a treatable cause of chronic kidney disease Gene therapy for Dravet syndrome: promises and impact on disease trigger and secondary modifications Neuropathy and pain in Fabry disease The division of rare diseases research innovation at the national center for advancing translational sciences, NIH: mission, history, and current research activities Long-term treatment with insulin-like growth factor-1 in Phelan-McDermid syndrome: a case report
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1